CTSF expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.1434969051154E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.0181000000028E-05 |
Normal-vs-Stage2 |
9.364300E-02 |
Normal-vs-Stage3 |
4.34580038621846E-10 |
Normal-vs-Stage4 |
2.24342766586005E-12 |
Stage1-vs-Stage2 |
8.654400E-01 |
Stage1-vs-Stage3 |
1.233990E-02 |
Stage1-vs-Stage4 |
1.74691000000005E-05 |
Stage2-vs-Stage3 |
4.003600E-01 |
Stage2-vs-Stage4 |
4.274000E-02 |
Stage3-vs-Stage4 |
1.097650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.89848137210902E-14 |
Normal-vs-AfricanAmerican |
7.469800E-01 |
Normal-vs-Asian |
9.313600E-01 |
Caucasian-vs-AfricanAmerican |
2.418300E-02 |
Caucasian-vs-Asian |
2.250800E-01 |
AfricanAmerican-vs-Asian |
9.459600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.16679945891963E-10 |
Normal-vs-Female |
5.77899999965048E-07 |
Male-vs-Female |
9.929400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.206400E-01 |
Normal-vs-Age(41-60Yrs) |
2.96149999967632E-07 |
Normal-vs-Age(61-80Yrs) |
7.6332273835078E-12 |
Normal-vs-Age(81-100Yrs) |
1.92248999999478E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.739600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.658200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.841800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.602600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.851200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.829600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.841800E-01 |
Normal-vs-Grade 2 |
1.168430E-04 |
Normal-vs-Grade 3 |
2.92019999958981E-07 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
3.507000E-01 |
Grade 1-vs-Grade 3 |
1.840150E-01 |
Grade 1-vs-Grade 4 |
8.476900E-03 |
Grade 2-vs-Grade 3 |
1.408810E-01 |
Grade 2-vs-Grade 4 |
2.90250001810932E-09 |
Grade 3-vs-Grade 4 |
2.13829999999859E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.80400000388192E-08 |
Normal-vs-ccB subtype |
4.37180000000259E-05 |
ccA subtype-vs-ccB subtype |
5.084000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.2715000004896E-07 |
Normal-vs-N1 |
1.322820E-03 |
N0-vs-N1 |
2.210200E-01 |
|
|